Skip to main content
. 2021 Dec 23;40(3):437–443. doi: 10.1016/j.vaccine.2021.12.012

Fig. 5.

Fig. 5

Correlation between anti-RBD and neutralising antibodies following COVID-19 vaccination. SARS-CoV. 2, severe acute respiratory syndrome coronavirus 2; RBD, receptor binding domain of viral spike protein.